A transversal approach based on multidisciplinary team meetings model
- Screening tools and AI
- Genomic expression testing
- IDC and pre-malignant lesion
- Updated standards in HR+ non metastatic disease
- HER2+ non metastatic management
- Triple negative non metastatic
- Breast cancer in elderly women